The U.K.’s biggest pharmaceutical firm has agreed to take over the Seattle-based company, which is developing a potential vaccine for two common respiratory diseases
The trucker's lawyers rejected an attempt to resurrect the company shortly after an auction in bankruptcy court raised nearly $1.9 billion for a swath of terminals around the country.
The partnership will focus on the collection, transportation, breaking down and processing of end-of-life lithium-ion EV batteries from the midwest and eastern U.S.